Weight Management
Physician-guided peptide programs for sustainable weight loss
The real problem with weight loss
If you've struggled with weight loss, it's probably not because you lack willpower. Modern research has fundamentally changed how we understand weight regulation. Your body has a complex system of hormones that control hunger, fullness, and how your metabolism processes energy — and for many people, that system doesn't work the way it should.
GLP-1 peptide therapy works with your body's own signaling pathways to help restore that balance. It's not a shortcut, and it's not a magic pill. It's a medical tool that, combined with lifestyle changes, can help people achieve meaningful, sustainable weight loss when diet and exercise alone haven't been enough.
What is GLP-1 peptide therapy?
GLP-1 stands for glucagon-like peptide-1. It's a hormone your body naturally produces in the gut after you eat. GLP-1 does several things: it tells your brain you're full, it slows stomach emptying so you stay satisfied longer, and it helps regulate blood sugar by triggering insulin release when needed.
GLP-1 receptor agonists are medications that mimic this natural hormone but last much longer in your body. Where your natural GLP-1 is broken down within minutes, therapeutic versions can work for days, providing sustained appetite regulation and metabolic support.
This isn't a new or experimental concept. GLP-1 therapies have been studied in large clinical trials involving tens of thousands of patients, and the results have been significant enough to change how the medical community approaches weight management.
How it works in your body
- Appetite signaling: GLP-1 receptor agonists act on the hypothalamus — the part of your brain that regulates hunger. They reduce the intensity of hunger signals, making it easier to eat appropriate portions without feeling deprived.
- Gastric emptying: These peptides slow the rate at which food leaves your stomach. This means you feel fuller for longer after meals, naturally reducing the urge to snack or overeat.
- Blood sugar regulation: GLP-1 therapy enhances insulin secretion in response to meals and reduces glucagon production, helping maintain stable blood sugar levels. This is particularly beneficial for patients with insulin resistance or pre-diabetes.
- Metabolic support: Emerging research suggests GLP-1 agonists may have broader metabolic effects, including potential cardiovascular benefits. The STEP and SELECT trials have shown reductions in cardiovascular events in certain patient populations.
Peptides used in weight management
Semaglutide
Semaglutide is an FDA-approved GLP-1 receptor agonist. It was approved for chronic weight management under the brand name Wegovy, and for type 2 diabetes as Ozempic. Clinical trials showed average weight loss of 15–17% of body weight over 68 weeks when combined with lifestyle modifications.
Regulatory status: Semaglutide is FDA-approved. Due to current FDA enforcement actions, compounded semaglutide availability is restricted. Your physician will discuss whether commercially manufactured semaglutide or alternative options are appropriate for your situation.
Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist — meaning it activates two incretin pathways rather than one. FDA-approved as Mounjaro for type 2 diabetes and Zepbound for weight management, clinical trials showed average weight loss of 20–22% of body weight. It represents the most effective pharmaceutical approach to weight loss currently available.
Regulatory status: Tirzepatide is FDA-approved. Like semaglutide, compounded versions face regulatory restrictions. Availability depends on current FDA guidance and your physician's clinical judgment.
What to expect: a realistic timeline
Potential side effects
Like all medications, GLP-1 therapy can cause side effects. The most common are gastrointestinal — nausea, constipation, diarrhea, and stomach discomfort. These are typically mild to moderate and tend to improve over the first few weeks as your body adjusts. Starting at a low dose and gradually increasing (dose titration) helps minimize these effects.
Less common side effects include headache, fatigue, and dizziness. Serious side effects are rare but can include pancreatitis and gallbladder issues. Your physician will review your complete health history to assess your risk profile before prescribing.
Who is NOT a candidate
GLP-1 therapy is not appropriate for everyone. Your physician may determine it's not right for you if:
- You have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- You have a history of pancreatitis
- You are pregnant, planning to become pregnant, or breastfeeding
- You have severe gastrointestinal disease (e.g., gastroparesis)
- Your BMI and health profile don't meet clinical criteria for pharmacological weight management
This is one of the reasons a physician review is essential — not everyone should be on these medications, and a responsible provider will tell you when they're not appropriate.
The Meridian approach
Weight management at Meridian isn't about prescribing a medication and sending you on your way. Here's what our process actually looks like:
- Comprehensive physician review: A licensed physician evaluates your health history, current medications, body composition, and goals to determine if GLP-1 therapy is appropriate and safe for you.
- Lab work when needed: Your physician may order blood work to check metabolic markers, thyroid function, kidney function, and other relevant values before starting treatment.
- Gradual dose titration: You start at the lowest effective dose. Your physician adjusts upward based on your response and tolerance — never faster than is clinically appropriate.
- Ongoing monitoring: Regular check-ins to track progress, manage side effects, and adjust your protocol. This isn't a set-it-and-forget-it prescription.
- Honest guidance: If the medication isn't working for you, or if side effects are problematic, your physician will recommend alternative approaches. The goal is your health, not a subscription.
Frequently asked questions
How much weight can I expect to lose?
Clinical trials show average weight loss of 15–22% of body weight over 12–18 months, depending on the medication used. However, individual results vary significantly. Factors like starting weight, adherence to lifestyle modifications, metabolic health, and genetics all play a role. Your physician will set realistic expectations based on your specific situation.
Do I need to diet and exercise while on GLP-1 therapy?
Yes. GLP-1 therapy is most effective when combined with a reduced-calorie diet and increased physical activity. The medication makes it easier to stick to these changes by reducing hunger and improving satiety, but it works best as part of a comprehensive approach — not as a standalone solution.
What happens when I stop taking the medication?
This is an important and honest conversation. Research shows that many patients regain some weight after discontinuing GLP-1 therapy. This is why building sustainable lifestyle habits during treatment is critical. Some patients may benefit from long-term or maintenance-dose therapy. Your physician will discuss a long-term plan with you.
Is this the same as what I've seen on social media?
GLP-1 medications like semaglutide and tirzepatide have received significant media attention. While the medications themselves are well-studied and FDA-approved, much of the social media conversation oversimplifies how they work and who they're for. At Meridian, every prescription requires a physician evaluation. We don't prescribe based on cosmetic goals alone — there must be a clinical indication.
Ready to start a weight management program?
Request GLP-1 therapy during your assessment. Your physician will review your case and determine if it's right for you.